The estimated Net Worth of J Rex Iiifwhc Holdings, Llc... is at least $16.2 Million dollars as of 23 February 2022. J Llc owns over 693,477 units of H-CYTE stock worth over $16,211,588 and over the last 4 years J sold HCYT stock worth over $0.
Sign up
J Llc HCYT stock SEC Form 4 insiders trading
J has made over 1 trades of the H-CYTE stock since 2022, according to the Form 4 filled with the SEC. Most recently J exercised 693,477 units of HCYT stock worth $6,935 on 23 February 2022.
The largest trade J's ever made was exercising 693,477 units of H-CYTE stock on 23 February 2022 worth over $6,935. On average, J trades about 346,739 units every 0 days since 2020. As of 23 February 2022 J still owns at least 16,211,588 units of H-CYTE stock.
You can see the complete history of J Llc stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Insiders trading at H-CYTE
Over the last 6 years, insiders at H-CYTE have traded over $0 worth of H-CYTE stock and bought 60,000 units worth $8,050 . The most active insiders traders include Todd Rfwhc Holdings, Llc Wa..., J Rex Iiifwhc Holdings, Llc..., and Michael Yurkowsky. On average, H-CYTE executives and independent directors trade stock every 286 days with the average trade being worth of $10,590,590. The most recent stock trade was executed by J Rex Iiifwhc Holdings, Llc... on 23 February 2022, trading 693,477 units of HCYT stock currently worth $6,935.
What does H-CYTE do?
H-CYTE, Inc., a biopharmaceutical company, develops and delivers various treatments for patients with chronic respiratory and pulmonary disorders. The company develops and implements treatment options in autologous cellular therapy to treat chronic lung disorders. It has a product supply agreement with Rion, LLC to develop and distribute biologics for chronic obstructive pulmonary disease. The company is headquartered in Tampa, Florida.
What does H-CYTE's logo look like?
Complete history of J Llc stock trades at H-CYTE
H-CYTE executives and stock owners
H-CYTE executives and other stock owners filed with the SEC include:
-
William Horne,
Chairman of the Board -
Robert Greif,
Pres -
Jeremy Daniel,
Chief Financial Officer -
Jeremy Daniel,
Chief Financial Officer -
Michael W. Yurkowsky,
CEO & Director -
Michael Yurkowsky,
Director -
Raymond Monteleone,
Director -
Robert Greifas,
President, Chief Executive Officer -
Dr. Tanya Rhodes Ph.D.,
Chief Technology Officer -
Jeffery Wright CPA, CPA,
Controller & Principal Accounting Officer -
J Rex Iiifwhc Holdings, Llc...,
-
Todd Rfwhc Holdings, Llc Wa...,
-
Frederick Jcfrs Investments...,
-
Robert Smith Greif,
Chief Executive Officer -
Todd Rfwhc Bridge, Llc Wagner,